The impact of atherosclerotic cardiovascular disease, dyslipidaemia and lipid lowering therapy on Coronavirus disease 2019 outcomes: an examination of the available evidence
(Hinzugefügt: 20.06.2021 um 17:55 Uhr)
Elderly male with cardiovascular-related comorbidities has a higher rate of fatal outcomes: a retrospective study in 602 patients with COVID-19
(Hinzugefügt: 19.04.2021 um 08:53 Uhr)
0 TOTAL VIEWS Suggest a Research Topic > SHARE ON 0 0 0 New EDITORIAL ARTICLE Front. Cardiovasc. Med. | doi: 10.3389/fcvm.2021.686495 Title COVID-19 Mechanisms on Cardio-Vascular Dysfunction, From Membrane Receptors to Immune Response
(Hinzugefügt: 30.03.2021 um 19:27 Uhr)
Association between regional distributions of SARS-CoV-2 seroconversion and out-of-hospital sudden death during the first epidemic outbreak in New York
(Hinzugefügt: 21.01.2021 um 08:51 Uhr)
Assessment of Neutrophil Extracellular Traps in Coronary Thrombus of a Case Series of Patients With COVID-19 and Myocardial Infarction
(Hinzugefügt: 30.12.2020 um 11:54 Uhr)
Chest CT–derived pulmonary artery enlargement at the admission predicts overall survival in COVID-19 patients: insight from 1461 consecutive patients in Italy
(Hinzugefügt: 30.12.2020 um 11:53 Uhr)
Renin–angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis
(Hinzugefügt: 18.12.2020 um 10:14 Uhr)
Comparison of Infection Risks and Clinical Outcomes in Patients with and without SARS‐CoV‐2 Lung Infection under Renin‐Angiotensin‐Aldosterone‐System Blockade ‐ Systematic Review and Meta‐Analysis
(Hinzugefügt: 09.12.2020 um 09:12 Uhr)